Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
AIDS and Behavior
Published in: AIDS and Behavior 8/2011

01-11-2011 | Original Paper

Adolescent Health-Risk Sexual Behaviors: Effects of a Drug Abuse Intervention

Authors: Hyman Hops, Timothy J. Ozechowski, Holly B. Waldron, Betsy Davis, Charles W. Turner, Janet L. Brody, Manuel Barrera

Published in: AIDS and Behavior | Issue 8/2011

Login to get access

Abstract

Adolescents who abuse substances are more likely to engage in health-risking sexual behavior (HRSB) and are at particularly high risk for HIV/AIDS. Thus, substance abuse treatment presents a prime opportunity to target HIV-risk behaviors. The present study evaluated a one-session HIV-risk intervention embedded in a controlled clinical trial for drug-abusing adolescents. The trial was conducted in New Mexico and Oregon with Hispanic and Anglo adolescents. Youths were randomly assigned to individual cognitive behavior therapy (CBT) or to an integrated behavioral and family therapy (IBFT) condition, involving individual and family sessions. The HIV-specific intervention was not associated with change. IBFT and CBT were both efficacious in reducing HIV-risk behaviors from intake to the 18-month follow-up for high-risk adolescents. For low-risk adolescents, CBT (versus IBFT) was more efficacious in suppressing HRSB. These data suggest that drug abuse treatments can have both preventative and intervention effects for adolescents, depending on their relative HIV-risk.
Appendix
Available only for authorised users
Literature
1.
Institute of Medicine. Committee on Prevention and Control of Sexually Transmitted Diseases. The hidden epidemic: confronting sexually transmitted diseases. Washington DC: National Academy Press; 1997.
2.
Centers for Disease Control and Prevention. Surveillance summaries. Morbidity and Mortality weekly report 53. No. SS-2; 2004.
3.
Weinstock H, Berman S, Cates W Jr. Sexually transmitted diseases among American youth: incidence and prevalence estimates. Perspect Sex Reprod Health. 2004;36(1):6–10.PubMedCrossRef
4.
Sayegh MA, Fortenberry JD, Anderson J, Orr DP. Relationship quality, coital frequency, and condom use as predictors of incident genital Chlamydia trachomatis infection among adolescent women. J Adolesc Health. 2005;37:163.PubMedCrossRef
5.
Metzger DS, Woody GE, O’Brien CP. Drug treatment as HIV Prevention: a research update. J Acquir Immune Defic Syndr. 2010;55(Supp1):S32–6.PubMed
6.
Woody GE, VanEtten-Lee ML, McKirnan D, et al. Substance use among men who have sex with men: comparison with a national household survey. J Acquir Immune Defic Syndr. 2001;27:86–90.PubMedCrossRef
7.
Ary DV, Duncan TE, Duncan SC, Hops H. Adolescent problem behavior: the influence of parents and peers. Behav Res Ther. 1999;37:217–30.PubMedCrossRef
8.
Kirby D. Antecedents of adolescent initiation of sex, contraceptive use and pregnancy. Am J Health Behav. 2002;26:473–85.PubMed
9.
St. Lawrence JS, Crosby RA, Brasfield TL, O’Bannon RE III. Reducing STD and HIV risk behavior of substance-dependent adolescents: a randomized controlled trial. J Consult Clin Psychol. 2002;70:1010–21.PubMedCrossRef
10.
Tildesley EA, Hops H, Ary D, Andrews JA. Multitrait-multimethod model of adolescent deviance, drug use, academic, and sexual behaviors. J Psychopathol Behav Assess. 1995;17:185–215.CrossRef
11.
Capaldi DM, Stoolmiller M, Clark S, Owen LD. Heterosexual risk behaviors in at-risk young men from early adolescence to young adulthood: prevalence, prediction, and STD contraction. Dev Psychol. 2002;38:394–406.PubMedCrossRef
12.
Walkup J, Blank MB, Gonzalez JS, et al. The impact of mental health and substance abuse factors on HIV prevention and treatment. J Acquir Immune Defic Syndr. 2008;47(Supp1):S15–9.PubMed
13.
Brown LS Jr, Kritz S, Muhammad A, et al. Disparities in health services for HIV/AIDS, Hepatitus C virus, and sexually transmitted infections: role of substance abuse treatment programs. J Addict Med. 2009;3(2):95–102.PubMedCrossRef
14.
Ozechowski TJ, Waldron HB. Assertive outreach strategies for narrowing the adolescent substance abuse treatment gap: implications for research, practice, and policy. J Behav Health Serv Res. 2010;37(1):40–63.PubMedCrossRef
15.
Peterson JL, Marin G. Issues in the prevention of AIDS among Black and Hispanic men. Am Psychol. 1988;43:871–7.PubMedCrossRef
16.
Rounds-Bryant JL, Staab J. Patient characteristics and treatment outcomes for African American, Hispanic, and White adolescents in DATOS-A. J Adolesc Res. 2001;16(6):624–41.CrossRef
17.
Marvel F, Rowe CL, Colon-Perez L, DiClemente RJ, Liddle HA. Multidimensional family therapy HIV/STD risk-reduction intervention: an integrative family-based model for drug-involved juvenile offenders. Fam Process. 2009;48(1):69–84.PubMedCrossRef
18.
Waldron HB, Turner CW. Evidence-based psychosocial treatments for adolescent substance abuse. J Clin Child Adolesc Psychol. 2008;37(1):238–61.PubMedCrossRef
19.
Dennis M, Godley SH, Diamond G, et al. The Cannabis Youth Treatment (CYT) Study: main findings from two randomized trials. J Subst Abuse Treat. 2004;27(3):197–213.PubMedCrossRef
20.
Waldron HB, Slesnick N, Brody JL, Turner CW, Peterson TR. Treatment outcomes for adolescent substance abuse at 4- and 7-month assessments. J Consult Clin Psychol. 2001;69:802–13.PubMedCrossRef
21.
DiClemente RJ, Wingood GM, Harrington KF, et al. Efficacy of an HIV prevention intervention for African American adolescent girls: a randomized controlled trial. J Am Med Assoc. 2004;292:171–9.CrossRef
22.
Jemmott JB, Jemmott LS, Fong GT, McCaffree K. Reducing HIV risk-associated sexual behavior among African American adolescents: testing the generality of intervention effects. Am J Community Psychol. 1999;7:161–87.CrossRef
23.
Slonim-Nevo V. The effect of HIV/AIDS prevention intervention for Israeli adolescents in residential centers: results at 12-month follow-up. Soc Work Res. 2001;25(2):71–88.
24.
Villarruel AM, Jemmott JB, Jemmott LS, Ronis DL. Predictors of sexual intercourse and condom use intentions among Spanish-dominant Latino youth. Nurs Res. 2004;53(3):172–81.PubMedCrossRef
25.
Jemmott JB, Jemmott LS, Fong GT. Reductions in HIV risk-associated sexual behaviors among Black male adolescents: effects of an AIDS prevention intervention. Am J Public Health. 1992;82(3):372–7.PubMedCrossRef
26.
Main DS, Iverson DC, McGloin J, Banspach SW. Preventing HIV infection among adolescents: evaluation of a school-based education program. Prev Med. 1994;23(4):409–17.PubMedCrossRef
27.
Kirby D, Barth RP, Leland N, Fetro JV. Reducing the risk: impact of a new curriculum on sexual risk-taking. Fam Plann Perspect. 1991;23(6):253–63.PubMedCrossRef
28.
St. Lawrence JS, Brasfield TL, Jefferson KW, Alleyne E, O’Bannon RE, Shirley A. Cognitive-behavioral intervention to reduce African-American adolescents’ risk for HIV infection. J Consult Clin Psychol. 1995;63(2):221–37.PubMedCrossRef
29.
Kirby DB, Laris BA, Rolleri LA. Sex and HIV education programs: their impact on sexual behaviors of young people throughout the world. J Adolesc Health. 2007;40:206–17.PubMedCrossRef
30.
Coyle KK, Kirby DB, Robin LE, Banspach SW, Baumler E, Glassman JR Jr. ALL4YOU! A randomized trial of an HIV, other STDs, and pregnancy prevention intervention for alternative school students. AIDS Educ Prev. 2006;18:187–203.PubMedCrossRef
31.
DiClemente RJ, Salazar LF, Crosby RA. A review of STD/HIV preventive interventions for adolescents: sustaining effects using an ecological approach. J Pediatr Psychol. 2007;2(8):888–906.CrossRef
32.
Donenberg GR, Paikoff R, Pequegnat W. Introduction to the special section on families, youth and HIV: family-based interventional studies. J Pediatr Psychol. 2006;31(9):869–73.PubMedCrossRef
33.
Prado G, Pantin H, Briones E, et al. A randomized controlled trial of a parent-centered intervention in preventing substance use and HIV risk behaviors in Hispanic adolescents. J Consult Clin Psychol. 2007;75(6):914–26.PubMedCrossRef
34.
Lederman RP, Mian TS. The parent-adolescent relationship education (PARE) program: a curriculum for prevention of STDs and pregnancy in middle school youth. Behav Med. 2003;29(1):33–41.PubMedCrossRef
35.
Sperber E, McKay MM, Bell CC, Petersen I, Bhana A, Paikoff R. Adapting and disseminating a community-collaborative evidence-based HIV/AIDS prevention programme: lessons from the history of CHAMP. Vulnerable Child Youth Stud. 2008;3:150–8.PubMedCrossRef
36.
DiIorio C, McCarty F, Resnicow K, Lehr S, Denzmore S. REAL Men: a group-randomized trial of an HIV prevention intervention for adolescent boys. Res Pract. 2007;97(6):1084–9.
37.
Tapia MI, Schwartz SJ, Prado G, Lopez B, Pantin H. Parent-Centered Intervention: a practical approach for preventing drug abuse in Hispanic adolescents. Res Soc Work Pract. 2006;16(2):146–65.CrossRef
38.
Murry VM, Berkel C, Brody GH, Gibbons M, Gibbons FX. The strong African American families program: longitudinal pathways to sexual risk reduction. J Adolesc Health. 2007;41:333–42.PubMedCrossRef
39.
Alexander JF, Parsons BV. Functional family therapy: principles and procedures. Carmel: Brooks/Cole; 1982.CrossRef
40.
Liddle HA, Rowe CL, Dakof GA, Ungaro RA, Henderson CE. Early intervention for adolescent substance abuse: pretreatment to posttreatment outcomes of a randomized clinical trial comparing multidimensional family therapy and peer group treatment. J Psychoact Drugs. 2004;36:49–63.CrossRef
41.
Marlatt BA, Gordon JR. Relapse prevention. New York: Guilford Press; 1985.
42.
Monti PM, Rohsenow DJ, Rubonis AV, et al. Cue exposure with coping skills treatment for Male alcoholics: a preliminary investigation. J Consult Clin Psychol. 1993;61:1011–9.PubMedCrossRef
43.
Rotheram-Borus MJ. Testimony at hearing; The risky business of adolescence: how to help teens stay safe. Washington, DC: Select Committee on Children, Youth and Families. U. S. House of Representatives; 1991.
44.
Woody GE. Research findings on psychotherapy of addictive disorders. Am J Addict. 2003;12:S19–26.PubMed
45.
Kirby DB, Baumler E, Coyle KK, et al. The “Safer Choices” intervention: its impact on the sexual behaviors of different subgroups of high school students. J Adolesc Health. 2004;35:442–52.PubMed
46.
Jemmott JB, Jemmott LS, Fong GT. Abstinence and safer sex HIV risk-reduction interventions for African American adolescents: a randomized controlled trial. J Am Med Assoc. 1998;279:1529–36.CrossRef
47.
Walter HJ, Vaughan RD, Ragin DF, Cohall AT, Kasen S, Fulilove RE. Prevalence and correlates of AIDS-risk behaviors among urban minority high school students. Prev Med. 1993;22:813–24.PubMedCrossRef
48.
Johnston LD, O’Malley PM, Bachman JG, Schulenberg JE. Monitoring the future: national results on adolescent drug use. Overview of key findings 2008. Bethesda: National Institute on Drug Abuse; 2009.
49.
Substance Abuse and Mental Health Services Administration (SAHMSA). Results from the 2006 national survey on drug use and health: national findings. Rockville: Office of Applied Studies; 2007. NSDUH Series H-32, DHHS Publication No. SMA 07-4293.
50.
Grunbaum JA, Kann L, Kinchen S, et al. Youth risk behavior surveillance—United States, 2003 (Abridged). J Sch Health. 2004;74:307–24.PubMedCrossRef
51.
Villarruel AM, Jemmott JB III, Jemmott LS. A randomized controlled trial testing an HIV prevention intervention for Latino youth. Arch Pediatr Adolesc Med. 2006;160:772–7.PubMedCrossRef
52.
Liddle HA, Dakof GA, Henderson C, Rowe C. Implementation outcomes of Multidimensional Family Therapy-Detention to community. Int J Offender Ther Comp Criminol. doi:10.​1177/​0306624X10366960​.
53.
Waldron HB, Brody JL, Slesnick N. Integrative behavioral and family therapy for adolescent substance abuse. In: Monti PM, Colby SM, O’Leary TA, editors. Adolescents, alcohol, and substance abuse: reaching teens through brief interventions. New York: Guilford Press; 2001. p. 216–43.
54.
Alexander JF, Parsons BV, Pugh C. Blueprints for violence prevention. Colorado: Venture; 1998.
55.
Azrin NH, Donohue B, Besalel VA, Kogan ES, Acierno R. Youth drug abuse treatment: a controlled study. J Child Adolesc Subst Abuse. 1994;3:1–16.CrossRef
56.
Brown SA, Meyers MG, Mott MA, Vik PW. Correlates of success following treatment for adolescent substance abuse. Appl Prev Psychol. 1994;3:61–73.CrossRef
57.
Achenbach TM. Manual for the child behavior checklist and the 1991 profile. Burlington: University of Vermont Department of Psychiatry; 1991.
58.
Beck AT, Steer RA, Garbin MG. Psychometric properties of the Beck Depression Inventory: twenty-five years of evaluation. Clin Psychol Rev. 1988;8:77–100.CrossRef
59.
Monti PM, Abrams DB, Kadden RM, Cooney NL. Treating alcohol dependence. London: Gilford Press; 1989.
60.
Kadden RM, Cooney NL, Getter H, Litt MD. Matching alcoholics to coping skills or interactional therapies: posttreatment results. J Consult Clin Psychol. 1989;57(6):698–704.PubMedCrossRef
61.
Barton C, Alexander JF. Functional family therapy. In: Gurman AS, Kniskern DP, editors. Handbook of family therapy. New York: Brunner/Mazel; 1981. p. 403–43.
62.
DiClemente RJ, Peterson JL, editors. Preventing AIDS: theories and methods of behavioral interventions. New York: Plenum Press; 1994.
63.
Anderson JE, Kann L, Holtzman D, Arday S, Truman B, Kolbe L. HIV/AIDS knowledge and sexual behavior among high school students. Fam Plann Perspect. 1990;22:252–5.PubMedCrossRef
64.
Catania JA, Coates TJ, Stall R, et al. Prevalence of AIDS-related risk factors and condom use in the United States. Science. 1992;258:1101–6.PubMedCrossRef
65.
DiClemente RJ. Adolescents and AIDS: current research, prevention strategies, and policy implications. In: Temoshok L, Baum A, editors. Psychosocial perspectives on AIDS: etiology, prevention, and treatment. Hillsdale: Lawrence Erlbaum Associates, Inc; 1990.
66.
Cates W Jr, Stone KM. Family planning, sexually transmitted diseases and contraceptive choice: a literature update—Part I. Fam Plann Perspect. 1992;24:75–84.PubMedCrossRef
67.
Van de Perre P, Jacobs D, Sprecher-Goldberger S. The latex condom, an efficient barrier against sexual transmission of AIDS-related viruses. AIDS. 1987;1:49–52.PubMed
68.
Kamb ML, Fishbein M, Douglas JM, et al. Efficacy of risk-reduction counseling to prevent Human Immunodeficiency Virus and sexually transmitted diseases. J Am Med Assoc. 1998;280(13):1161–7.CrossRef
69.
Rahdert E. The adolescent assessment and referral manual. Rockville: National Institute on Drug Abuse; 1991. DHHS Publication ADM-91-1735.
70.
Latimer WW, O’Brien MS, McDouall J, Toussova O, Floyd LJ, Vazquez M. Screening for “substance abuse” among school-based youth in Mexico using the Problem Oriented Screening Instrument for Teenagers (POSIT). Subst Use Misuse. 2004;39:307–29.PubMedCrossRef
71.
Leccese M, Waldron HB. Assessing adolescent substance use: a critique of current measurement instruments. J Subst Abuse Treat. 1994;11:553–63.PubMedCrossRef
72.
Santisteban DA, Tejeda M, Dominicis C, Szapocznik J. An efficient tool for maladaptive family functioning in adolescent drug abusers: the problem oriented screening instrument for teenagers. Am J Drug Alcohol Abuse. 1999;25:197–206.PubMedCrossRef
73.
Singer LT, Linares TJ, Ntiri S, Henry R, Minnes S. Psychosocial profiles of older adolescent MDMA users. Drug Alcohol Depend. 2004;74:245–52.PubMedCrossRef
74.
Rowe CL, Wang W, Greenbaum P, Liddle HA. Predicting HIV/STD risk level and substance use disorders among incarcerated adolescents. J Psychoact Drugs. 2008;40:503–12.CrossRef
75.
Winters KC, Botzet AM, Fahnhorst T, Baumel L, Lee S. Impulsivity and its relationship to risky sexual behaviors and drug abuse. J Child Adolesc Subst Abuse. 2009;18:43–56.PubMedCrossRef
76.
Clogg CC. Latent class models. In: Arminger G, Clogg CC, Sobell ME, editors. Handbook of statistical modeling for the social and behavioral sciences. New York: Plenum Press; 1995. p. 311–59.
77.
78.
Skrondal A, Rabe-Hesketh S. Generalized latent variable modeling: multilevel, longitudinal, and structural equation models. New York: Chapman & Hall/CRC; 2004.CrossRef
79.
Godley SH, Dennis ML, Godley MD, Funk RR. Thirty-month relapse trajectory cluster groups among adolescents discharged from outpatient treatment. Addiction. 2004;99(2):129–39.PubMedCrossRef
80.
Latimer WW, Winters KC, Stinchfield R, Traver RE. Demographic, individual, and interpersonal predictors of adolescent alcohol and marijuana use following treatment. Psychol Addict Behav. 2000;14:162–73.PubMedCrossRef
81.
Patterson GR, DeGarmo DS, Knutson N. Hyperactive and antisocial behaviors: comorbid or two points in the same process? Dev Psychopathol. 2000;12:91–106.PubMedCrossRef
82.
Guzman BL, Schlehofer-Sutton MM, Villanueva CM, Stritto MED, Casad BJ, Feria A. Let’s talk about sex: how comfortable discussions about sex impact teen sexual behavior. J Health Commun. 2003;8(6):583–98.PubMedCrossRef
83.
Eaton DK, Kann L, Kinchen S, et al. Centers for Disease Control, Prevention (CDC). Youth risk behavior surveillance—United States, 2007. MMWR Surveill Summ. 2008;57(4):1–131.PubMed
84.
Tschann JM, Flores E, de Groat SL, Deardorff J, Wibbelsman CJ. Condom negotiation strategies and actual condom use among Latino youth. J Adolesc Health. 2010;47:254–62.PubMedCrossRef
85.
Castro FG, Barrera M, Martinez CR. The cultural adaptation of prevention interventions: resolving tensions between fidelity and fit. Prev Sci. 2004;5(1):41–5.PubMedCrossRef
86.
Whaley AL, Davis KE. Cultural competence and evidence-based practice in mental health services: a complementary perspective. Am Psychol. 2007;62(6):563–74.PubMedCrossRef
Metadata
Title
Adolescent Health-Risk Sexual Behaviors: Effects of a Drug Abuse Intervention
Authors
Hyman Hops
Timothy J. Ozechowski
Holly B. Waldron
Betsy Davis
Charles W. Turner
Janet L. Brody
Manuel Barrera
Publication date
01-11-2011
Publisher
Springer US
Published in
AIDS and Behavior / Issue 8/2011
Print ISSN: 1090-7165
Electronic ISSN: 1573-3254
DOI
https://doi.org/10.1007/s10461-011-0019-7

Other articles of this Issue 8/2011

AIDS and Behavior 8/2011 Go to the issue

Original Paper

Improving Clinic Attendance and Adherence to Antiretroviral Therapy Through a Treatment Supporter Intervention in Uganda: A Randomized Controlled Trial

Original Paper

Telephone-Administered Motivational Interviewing Reduces Risky Sexual Behavior in HIV-Positive Late Middle-Age and Older Adults: A Pilot Randomized Controlled Trial

Original Paper

Depression and Neurocognitive Performance in Portuguese Patients Infected with HIV

Original Paper

Evaluation of a Peer Network-Based Sexual Risk Reduction Intervention for Men in Beer Halls in Zimbabwe: Results from a Randomized Controlled Trial

Original Paper

Feasibility and Promise of a Couple-Based HIV/STI Preventive Intervention for Methamphetamine-Using, Black Men Who have Sex with Men

Original Paper

Reducing Sexual HIV/STI Risk and Harmful Alcohol Use Among Female Sex Workers in Mongolia: A Randomized Clinical Trial
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits